With a price/sales ratio of 16.17, Ligand Pharmaceuticals Inc has a higher such ratio than 91.98% of stocks in our set.
Revenue growth over the past 12 months for Ligand Pharmaceuticals Inc comes in at -53.95%, a number that bests just 3.04% of the US stocks we're tracking.
Ligand Pharmaceuticals Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 33.96%, greater than the shareholder yield of 92.01% of stocks in our set.
Stocks with similar financial metrics, market capitalization, and price volatility to Ligand Pharmaceuticals Inc are KMPH, AKTS, PLUG, LJPC, and NUAN.
Ligand Pharmaceuticals Incorporated (LGND) Company Bio
Ligand Pharmaceuticals develops therapies that address the unmet medical needs of patients for a range of diseases, including hepatitis, multiple myeloma, muscle wasting, Alzheimers disease, dyslipidemia, diabetes, anemia, epilepsy, focal segmental glomerulosclerosis, and osteoporosis. The company was founded in 1987 and is based in La Jolla, California.
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Icagen, a Ligand Company, announced today the expansion of Icagen’s license agreement with Roche to develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders, by adding a second program to the agreement. The new program incorporates Icagen’s ion channel technology and expertise and is directed at a specific novel ion channel target relevant to neurodegenerative di
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has earned a $3 million milestone payment from Palvella Therapeutics as a result of Palvella raising $45 million in an oversubscribed Series C financing to leading biotechnology crossover and venture investors. The milestone payment will consist of $2 million in cash and $1 million in Palvella Series C Preferred Stock. Palvella is a privately-held rare disease biopharmaceutical company focused on develop